A B S T R A C T Despite the fact that gonorrhea is our most common reportable infectious disease, little is known about natural and acquired resistance to Neisseria gonorrhoeae. With the chimpanzee model, which mimics human gonococcal infection in signs, symptoms, and host response, a natural resistance to gonococcal challenge was found. One aspect of this natural resistance became evident when the cervix and oral pharynx resisted more gonococci than the urethra. Natural resistance was also shown when environmental factors were found to influence resistance to gonococcal pharyngitis. In addition to natural resistance a postinfectionacquired immunity to the gonococcus was demonstrated. Following gonococcal pharyngitis, this anatomical location successfully resisted more gonococci than were initially resisted. Similarly, more gonococci were successfully resisted in rechallenging the urethra. These findings are related to the clinic situation and suggest possible new approaches to gonorrhea control.
INTRODUCTION
It is not unusual for a patient to contract gonococcal urethritis many times. The development of clinically significant immunity to reinfection after gonorrhea is questioned by clinicians when treating the same patients who return with the same problem a week or a month after treatment for gonorrhea. The paradox of gonorrhea has recently been used to describe those patients who become reinfected despite significant increases of antigonococcal systemic antibody, local secretory IgA, and cell-mediated immunity (1) .
Contrasting with the repetitiousness of gonorrhea in some individuals is the fact that only one in five men A preliminary report was presented at the 13th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D. C., September 1973.
Received for publication 25 July 1974 and in revised form 17 February 1975. who experience a single sexual contact with an infected female develop gonorrhea (2) . The mechanism (or mechanisms) for this resistance is (or are) not understood, but natural or acquired immunity could possibly account for a portion of the 80% who escape infection.
Human volunteer experiments might be one avenue for answering the question of natural and acquired immunity in gonococcal resistance. Experimentally induced gonococcal urethritis had been accomplished as early as 1767 (3) , but more recent attempts to establish a reproducible infective technique were abandoned after an exhaustive number of experiments (4) . Somewhat later a reproducible technique was described (5) , but the infections were terminated after 5 days (6), because of potential problems involving the psychological and general health of the volunteers.' Such a short duration of infection was insufficient time for the host to develop immunity capable of terminating the infection, and, indeed, the time required for spontaneous termination of gonorrhea may exceed several months (7) .
An animal model has recently been described which mimics uncomplicated gonococcal infection in man with respect to incubation period, certain clinical manifestations, sexual transmission, local cellular response in the exudate, in vitro culture characteristics of the infection material, and systemic immune response (8) (9) (10) ). This animal model has now been used to answer the basic question: does immunity to reinfection develop in the course of a gonococcal infection? If immunity does ensue, related questions include the following: is it absolute or relative, and is it related to the dynamics of the initial infection, such as infective dose and duration of the prior infection (7) . During these experiments other information was obtained, such as that concerning the minimal infective inoculum of gonococci; natural immunity to Neisseria gonorrhoeae: gonococcal viru-'Kellogg, D. S. Personal communication.
lence determinants other than colony type (5, 11, 12) and pili (13, 14) ; infectivity of colony type 5 (15) ; and the dynamics of gonorrhea as influenced by its anatomical location (urethra, cervix, or pharynx).
METHODS
Chimpanzees. 16 adult chimpanzees participated in either all or a portion of the experiments. Not all chimpanzees participated in all experiments because of logistical and technical problems in handling adult chimpanzees. Three of the animals were female (nos. 12, 13, and 16). The animals were housed according to their compatibility, and usually chimpanzees of the same sex were caged together. If the sexes were mixed, sexual activity was noted, and this was documented only with animal 2 and a female not included in this study. Three chimpanzees (nos. 14, 15, and 16) were housed in indoor facilities at the Center for Disease Control (CDC chimpanzees) 2 and the others were kept in outdoor facilities at Chamblee, Ga. (CHB chimpanzees). Six of the animals (nos. 4, 6, 7, 10, 11, and 12) had been infected with N. gonorrhoeae in the urethra or cervix 2 yr previously. The remainder had had no prior gonococcal infection.
Gonococcal inocula. Two clinical isolates of N. gonorrhoeae (C and M) were obtained from men with gonococcal urethritis. These were isolated on selective media (16) and identified as N. gonorrhoeae on the basis of Gram stain, colonial morphology, oxidase reaction (utilizing a 1% solution of N,N-dimethyl-p-phenylenediamine monohydrochloride), and fermentation of dextose but not maltose, sucrose, lactose, fructose, or mannitol (fermentation medium consisted of 1% test carbohydrate in cystine tryptic agar medium). After two in vitro passes on GCB medium (GC base medium plus Isovitalex) 8 to ensure purity, the isolates were frozen at -900C in phosphate-buffered saline, pH 7.2, containing 10% glycerol. Multiple vials were frozen so that all challenges with C and M isolates were performed with gonococci that had not been passed in vitro more than three times.
Gonoccccal isolate T was a laboratory strain passed in vitro on GCB medium more than 500 times. These passes were selectively done to maintain colony type 1 (11) . Isolate K2 43562 was supplied by A. Reyn (Neisseria Department, Staten Seruminstitute, Copenhagen, Denmark) and was colony type 5 (15) .
Gonococci for chimpanzee inoculation were grown for 18 h in GCB medium. C, M, and T inocula consisted of greater than 95%o colony type the same broth, and pour plates were made from the higher dilutions. CFU were counted on that plate with the greatest number of discrete colonies. The sequence of gonococcal isolates inoculated into the chimpanzees was C, T, and M.
Chimpanzee inoculation. Urethral inoculations were similar to that previously described (8) . 1 ml of gonococcal suspension was introduced into the urethra by means of a plastic catheter. The number of gonococci inoculated into the first chimpanzees studied in the experiments varied until an understanding of the magnitude of minimal infective dose (MID) was ascertained. In these early experiments the dose used to infect was therefore not necessarily the MID, since smaller doses might also have infected. Subsequent initial inocula in other chimps were started at 100 CFU, and then challenge doses were increased by a factor of 10 until either infection occurred or high challenge doses were successfully resisted. The latter constituted the maximal challenge dose (MCD), and it did not necessarily reflect the maximal resistance dose (MIRD), since greater numbers of gonococci may have been resisted. If infection occurred, the MIDs were calculated as well as the MRDs which, according to the protocol, were usually a factor of 10 less than the MIDs.
Pharyngeal inoculation was done with the animal in a supine position. The tongue was depressed and 1 ml of gonococcal suspension was placed over the tonsils and into the oral pharynx. The initial inoculum contained 100 CFU, and subsequent inocula were progressively increased in a manner identical to that employed in the urethral challenges.
Cervical inoculation was performed with the chimpanzee in the lithotomy position, and the cervix was observed with the aide of a vaginal speculum. 1 ml of gonococcal suspension was placed onto the cervix with a pipette. The initial inoculum was 100 CFU, and this was increased by a factor of 10 until either infection occurred or a high challenge dose was resisted.
Detection of gonococcal infection. Specimens from the animals were cultured within a week after inoculation and weekly thereafter if a gonococcal infection was induced. Two consecutive negative cultures were obtained to document failure to infect or termination of infection.
Urethral specimens were obtained by inserting a bacterial loop 6 cm into the urethra. Cervical specimens were collected on a cotton-tipped applicator inserted into the cervical os after the latter was observed with a vaginal speculum. The rectal area was sampled by introducing a sterile cottontipped applicator 3 cm into the rectum. Oral pharynx specimens were obtained with a cotton-tipped applicator touched to both tonsils and the posterior aspect of the oral pharynx. All specimens were plated onto selective medium (16) and vancomycin, colistin, nystatin, and trimethoprim (VCNT) medium (selective medium without hemoglobin and containing 5 /Ag/ml of trimethoprim). The VCNT medium allowed colony typing of the primary isolate (17) ; it also suppressed an occasional Proteus which overgrew the surface of the standard selective medium (18) .
All cultures were incubated at 36.50C in a candle extinction jar and examined for growth at 24 and 48 h. Oxidase-positive colonies were further studied by Gram stain and sugar fermentation.
Rechallenge inoculations. Within 1 wk after termination of the initial infection with M isolate, the animals were rechallenged with M isolate starting with 103 CFU and proceeding as in the primary challenge until reinfection occurred or a high challenge dose failed to reinfect. Those animals reinfected with M isolate were cultured weekly until spontaneous termination of the infection. RESULTS 11 male chimpanzees participated in various aspects of the urethral challenges with N. gonorrhlocae. The first two gonococcal isolates inoculated into the urethras (isolates C and T) failed to induce urethritis. Five chimpanzees (nos. 1, 3, 5, 8, and 9) were challenged with C isolate, and the MICD varied from 108 to 10" CFU. Three chimpanzees (nos. 3, 5, and 8) were then challenged with T isolate, and the AMCDs ranged from 10' to 10' CFU. The colony types of these two inocula were greater than 95% type 1, and they were piliated, as shown by negative staining and transmission electron microscopy (13, 14) .
In contrast to the failure to induce urethritis with isolates C and T, all 11 male chimpanzees challenged The duration of the second urethral infection with M isolate ranged from 5 to 36 days with a mean of 17 days. This mean duration was shorter than the corresponding mean duration of the initial infection (29 days). The duration of the second urethritis was shorter than in the initial urethritis for six of the seven animals reinfected, but this was not statistically significant (P = 0.06 Sign test).
The relationship between the duration of the first urethral infection with M isolate and the degree of resistance to reinfection upon rechallenge with the same isolate is outlined in Table IV . The latter is represented by the MRD in those chimpanzees reinfected or the MCD in those that resisted reinfection. As shown in the table, the duration of the first infection showed no apparent relationship to the degree of resistance to rechallenge.
5 of these 11 male chimpanzees had experienced gonococcal urethritis 2 yr previously. MRDs in the first infection with M isolate were determined in four of these animals, and they ranged from 3.5 X 10' to 1.2 X 10' CFU with a geometric mean of 1.5 X 10' CFU. Of the six other chimpanzees infected with M isolate (those without prior gonorrhea), an MRD was determined in only one animal, and this was 1.4 X 10 CFU. The duration of the first infection with M isolate in the five chimpanzees infected previously ranged from 20 to 50 days, with a mean of 28 days. The duration of the first infection with M isolate in the other six chimpanzees was 21 to 41 days, with a mean of 30 days.
The cervices of two female animals were inoculated with M isolate. One resisted infection (MCD of 1.0 X 10" CFU), and the other was infected with 5.1X 10' CFU after resisting 5.0 X 10' CFU (Table V) . The geometric mean of the maximal number of gonococci resisted by these two animals in the cervical area was 2.2 x 10' CFU.
All 16 chimpanzees participated in various aspects of the pharyngeal challenges with N. gonorrhoeae. is also a natural resistance to initial infection. Evidence for this includes differences in numbers of gonococci successfullly resisted in the different anatomical sites commonly involved in gonococcal infections: the urethra, cervix, and oral pharynx. The numbers (geometric mean values) successfully resisted in the CHB chimpanzees were urethra, 1.4 X 101 CFU; cervix, 2.2 X 10' CFU; and oral pharynx, 1.6 X 108 CFU. Thus, the cervix and pharynx were resistant to approximately 100 thousand to 1 million more gonococci than the urethra. Other evidence for a natural immunity to gonorrhea was the difference in the resistance to gonococcal pharyngitis in relation to the geographic location of the chimpanzees i.e., differences between the CHB and the CDC animals. The CHB chimpanzees resisted 50 thousand times as many gonococci placed into the oral pharynx as the CDC animals (6.7 X 10' vs. 1.4 X 10' CFU). Anatomical and environmental factors can therefore influence the degree of resistance to infection with N. gonorrhoeae. The mechanism (mechanisms) for this natural resistance is (are) not understood, and our data do not give answers to the questions posed. N. meningitidis and N. lactamiica, however, were frequently isolated from the oral pharynx of the CHB chimpanzees, but they were never found in the CDC chimpanzees. N. meningitidis and N. lactamica were occasionally simultaneously present in the oral pharynx, but both were absent when the gonococcus was present in the oral pharynx. Bacterial interference in which gonococci are inhibited by meningococci has recently been described and suggested as a possible mechanism for a patient's resistance to gonococcal infection (19) (8) (9) (10) . Despite these similarities at least three major differences may exist between our experimental chimpanzee system and the natural infection in man.
In naturally acquired gonococcal urethritis the incubation period is typically 3 days (20) , and patients usually present themselves for treatment within 2 or 3 days after the onset of symptoms (21) . Treatment therefore arrests the infection within a week's duration, whereas the initial infection in our experimental urethritis ranged from 20 to 50 days, with a mean of 29.1 days, and the infection was allowed to terminate spontaneously. Although our data do not elucidate the mechanism of acquired immunity following gonorrhea, the duration of infection may influence the magnitude of several immunologic responses which, in turn, may play a role in acquired immunity. A longer duration of N. gonorrhoeae infection has been postulated to be one reason for greater humoral (6, (22) (23) (24) and celluar (25) immune responses in certain individuals. Reinfection in men may therefore be related to the fact that the short duration of infection before treatment may not give ample time for the degree of resistance to reinfection observed in the chimpanzees to develop.
A second major difference between our chimpanzee system and naturally acquired disease is that the chimpanzees were infected with a single N. gonorrhoeae isolate. The strain specificity of the immunity we describe is unknown, and it could vary from the meningococcal system where immunity is group specific (26, 27) and involves relatively few groups to the pneumococcal system where immunity is type specific and involves a relatively large number of types (28) . Re Our current investigations did not detect significant differences between urethral infections in chimpanzees with gonococcal urethritis 2 yr previously and chimpanzees not previously exposed to N. goniorrhocac. In those instances where AIRDs were determined with M\ isolate, the geometric mean AIRD for those animals previously infected was 1.5 x 103 CFU, and the NMRD for a single aninmal not previously infected was 1.4 X 103 CFU. The mean duration of infection with AM isolate in five chimpanzees previously infected was 28.2 davs, and the infection duration in five chimpanzees not previously infected was 30.0 days. This failure to demonstrate immunity 2 yr after gonococcal urethritis contrasts sharply with the immunity to M isolate demonstrated in this study and may be secondary to one or more factors. The rechallenge experiments with MI isolate detailed in this study were initiated within a week of the second negative culture which confirmed spontaneous eradication of the initial infection. The rechallenges were completed within a 2-nmo interval, and the duration of the immunity beyond this time was not tested and is unknown. Possibly there is a decline in immunity after a 2-yr interval. Another possibly important variable is that different gonococcal isolates were used in the infections 2 yr previously, and these were not available for rechallenge experiments. If immunity to N. gonorrhocae is strain specific, immunity to the previous inocula could still be present but undetected because of limited or no cross-immunity to MI isolate. Our data does not indicate which of these two mechanisms (or other mechanisms) accounts for the ease of reinfection.
Our main objective was to answer the question of whether immunity to gonococcal reinfection is acquired.
This was done because the presence of acquired immunity in other diseases suggested that acquired immunity via vaccine might be feasible. Conversely, the vaccine approach has not been as successful in diseases in which immunity to reinfection is nonexistent or of limited value. Our data on acquired immunity suggest that the vaccine approach may be of value in the control of the gonorrhea epidemic. This approach may be the only answer, since the disease is increasing (29) despite effective means for diagnosis and treatment.
